A Study on Seroconversion in HBeAg Antigen Positive Chronic Hepatitis B Patients with Tenofovir Therapy

Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 9

Abstract

Introduction: Chronic Hepatitis B remains most important risk factor for developing cirrhosis, hepatic decompensation and hepatocellular carcinoma. So treatment with tenofovir of HbeAg positive Chronic Hepatitis B and seroconversion is the major concern. Aim: To see the HbeAg and HbsAg loss after receiving tenofovic therapy for 6 and 12 months. Methodology: A hospital based prospective study conducted on 50 chronic hepatitis B infection with HbeAg antigen positive patients between age group 12 to 60 years, receiving tenofovir (300mg) was taken for study. HbeAg, HbsAg and liver enzyme status was checked at the end of 6 months and 12 months. Results: ALT level became normal (<19mg/ml) in 37.5 % of female patients at the end of 12 months study and in male it was 67.65%. Overall biochemical response was 58%. All patients were HbeAg reactive at the end of 6 months of tenofovir therapy but 48 percent became non reactive at the end of 12 months. Overall seroconverson was 36 percent at the end of 12 months. Conclusion: There is statistical significant number of HbeAg loss, normalization of ALT level and HbeAg seroconversion at the end of 1 year. HBV DNA level became undetectable level in all sero converted groups.

Authors and Affiliations

Pinaki Nath

Keywords

Related Articles

Ultrasound Evaluation of Dengue Fever

This study is to determine whether ultrasound is an important adjuvant to clinical and laboratory profile: to predict prognosis and assessing severity of disease with platelet correlation. ultrasonic variations seen in v...

Predisposing Factors, Prevention and Treatment of Trocar site Hernia

Laparoscopic cholecystectomy by two pioneer laparoscopic surgeons: Prof. Dr. Mederich Muhe of Germany in 1985 and Phillipe Mouret of France (Lyors – 1987) revolutionarised surgery and opened a new path for minimal access...

Randomised controlled trial comparing clinical response between hypo fractionated verses conventional fractionated radiotherapy in early stage Ca Larynx

Aim: The objective of the study is to compare the locoregional control in patients of early Ca larynx treated with hypofractionated versus conventional fractionated radiotherapy. Material and Methods: Patients with histo...

Role of Prophylactic Antibiotics in Bladder Management of Paraplegics – A Randomised Controlled Study

Introduction: Traumatic spinal cord injury is not an uncommon disease in the developing world. The most common cause being fall from heights. In spinal cord injured patients both bladder sensation and control are impaire...

Haematological Parameters in Neonatal Sepsis

Background: In neonatal sepsis, the haematological screening parameters and Creactive protein (CRP) have wide variations in performance. Objective: To evaluate the performance of haematological screening parameters and C...

Download PDF file
  • EP ID EP515061
  • DOI -
  • Views 122
  • Downloads 0

How To Cite

Pinaki Nath (2018). A Study on Seroconversion in HBeAg Antigen Positive Chronic Hepatitis B Patients with Tenofovir Therapy. Journal of Medical Science And clinical Research, 6(9), 390-396. https://www.europub.co.uk/articles/-A-515061